2020
DOI: 10.1177/1474515120924530
|View full text |Cite
|
Sign up to set email alerts
|

Delivering healthcare remotely to cardiovascular patients during COVID-19

Abstract: Background: Although attention is focused on addressing the acute situation created by the COVID-19 illness, it is imperative to continue our efforts to prevent cardiovascular morbidity and mortality, particularly during a period of prolonged social isolation which may limit physical activity, adversely affect mental health and reduce access to usual care. One option may be to deliver healthcare interventions remotely through digital healthcare solutions. Therefore, the aim of this paper is to bring together t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
130
0
4

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
2
1

Relationship

3
7

Authors

Journals

citations
Cited by 109 publications
(143 citation statements)
references
References 31 publications
(44 reference statements)
2
130
0
4
Order By: Relevance
“…These medications can cause cardiac toxicity, specifically QTc prolongation and Torsades de Pointes, especially in patients with hepatic or renal impairment [15]. In May 2020, the Australian Therapeutic Administration (TGA) updated its advice stating, "Based on the latest international data, use of hydroxychloroquine to treat COVID-19 is strongly discouraged, [21]. Clinical guidelines for the prevention, detection, and management of heart failure in Australia (2018) support the use of telemonitoring and structured telephone support for people with heart failure [22].…”
Section: Medications Examined To Treat Covid-19 May Bementioning
confidence: 99%
“…These medications can cause cardiac toxicity, specifically QTc prolongation and Torsades de Pointes, especially in patients with hepatic or renal impairment [15]. In May 2020, the Australian Therapeutic Administration (TGA) updated its advice stating, "Based on the latest international data, use of hydroxychloroquine to treat COVID-19 is strongly discouraged, [21]. Clinical guidelines for the prevention, detection, and management of heart failure in Australia (2018) support the use of telemonitoring and structured telephone support for people with heart failure [22].…”
Section: Medications Examined To Treat Covid-19 May Bementioning
confidence: 99%
“…We often lead the way through collaborating with patients and their families in practice and research from co-design to implementation. Not surprisingly, nurses are at the forefront of very innovative models of delivery, for which they are recognised internationally [28,29] Nurses are experts in identifying barriers and challenges in self-management and self-care for patients and take action by being in the vanguard of patient support strategies. Nurses have developed patient-education avatars, gamified applications, and incorporated trackers and engaged in social media in advance of other health disciplines [30][31][32].…”
Section: Leaders Advocates Innovators Educators and Morementioning
confidence: 99%
“…Amid a pandemic, these boards have temporarily altered their necessary requirements to accommodate telemedicine (Jaarsma et al, 2020). For instance, the medical personnel have been allowed to use non-HIPAA acquiescence digital tools including Skype, Zoom, FaceTime, and Cisco Webex to supplement the HIPAA compliant videoconferencing tools such as Updox, Microsoft Teams, Skype for Business, and VSee (Neubeck et al, 2020). Furthermore, the state pharmacy boards have temporarily allowed pharmacists to operate outside a licensed pharmacy because of the dangers of COVID-19.…”
Section: Legislations Followed To Deploy Online Health Servicesmentioning
confidence: 99%